PAF1 and Familial prostate cancer: The high degree of structural similarity between dermaseptin-PD-1, dermaseptin-PD-2 and dermaseptin B2 (Figure 2), especially that between the latter two peptides, may indicate similar anticancer effect of the two novel peptides, particularly on prostate cancer cells.